Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Efficacy of Seattle-PAP for the Respiratory Support of Premature Infants

NCT02210026 is registered in ClinicalTrials.gov with Seattle Children's Hospital as lead sponsor.

NCT NCT02210026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02210026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Efficacy of Seattle-PAP for the Respiratory Support of Premature Infants
Lead sponsor
Seattle Children's Hospital
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2014
Completion date
October 31, 2015
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia, newborn primary sleep apnea, respiratory distress syndrome in premature infants